Elevation of serum KL-6 levels during treatment with tumor necrosis factor-α inhibitor in patients with psoriasis

被引：9
|
作者：
Mabuchi, Tomotaka [1 ]
Yamaoka, Hanako [1 ]
Kawai, Mayu [1 ]
Ota, Tami [1 ]
Ozawa, Akira [1 ]
机构：
[1] Tokai Univ, Dept Dermatol, Sch Med, Isehara, Kanagawa 2591193, Japan
来源：
JOURNAL OF DERMATOLOGY | 2014年 / 41卷 / 12期
关键词：
AD HOC COMMITTEE; RHEUMATOID-ARTHRITIS; BIOLOGICAL DMARDS; JAPAN COLLEGE; SAFETY;
D O I：
10.1111/1346-8138.12681
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
下载
收藏
页码：1136 / 1137
页数：2
相关论文
共 50 条
  • [1] Elevation of serum KL-6 in patients with psoriasis treated with anti-tumour necrosis factor- therapy
    Higashi, Y.
    Tada, K.
    Shimokawa, M.
    Kawai, K.
    Kanekura, T.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2016, 41 (01) : 88 - 90
  • [2] Impact of anti-tumor necrosis factor- agents on serum levels of KL-6 and surfactant protein-D in patients with psoriasis
    Hayashi, Mitsuha
    Yanaba, Koichi
    Umezawa, Yoshinori
    Asahina, Akihiko
    Nakagawa, Hidemi
    JOURNAL OF DERMATOLOGY, 2017, 44 (09): : 1063 - 1066
  • [3] Elevation of Serum KL-6 mucin Levels in Patients with Cholangiocarcinoma
    Xu, Huanli
    Inagaki, Yoshinori
    Tang, Wei
    Guo, Qian
    Wang, Fengshan
    Seyama, Yasuji
    Midorikawa, Yutaka
    Gai, Ruoyan
    Kokudo, Norihiro
    Sugawara, Yasuhiko
    Nakata, Munehiro
    Makuuchi, Masatoshi
    HEPATO-GASTROENTEROLOGY, 2008, 55 (88) : 2000 - 2004
  • [4] Serum KL-6 levels in Japanese patients with psoriasis treated with secukinumab
    Kurita, Miki
    Kikuchi, Sota
    Umezawa, Yoshinori
    Asahina, Akihiko
    Nakagawa, Hidemi
    Yanaba, Koichi
    JOURNAL OF DERMATOLOGY, 2019, 46 (04): : E115 - E116
  • [5] Change in Serum KL-6 Level during Biologic Treatment for Psoriasis
    Hoashi, Toshihiko
    Miyazaki, Shun
    Ozaki, Saeko
    Ichiyama, Susumu
    Ito, Michiko
    Kanda, Naoko
    Saeki, Hidehisa
    JOURNAL OF NIPPON MEDICAL SCHOOL, 2023, 90 (02) : 194 - 201
  • [6] Elevation of serum KL-6 levels in 3 patients with rheumatoid arthritis treated with adalimumab
    Koiwa, Masahito
    Goto, Susumu
    Takenouchi, Kenji
    Takahasi, Kenji
    Kamada, Toshikazu
    Nakamura, Hiroshi
    MODERN RHEUMATOLOGY, 2012, 22 (01) : 147 - 151
  • [7] Serum KL-6 Levels in Patients with Lung Cancer
    Yoshimasu, Tatsuya
    Kawago, Mitsumasa
    Hirai, Yoshimitsu
    Oura, Shoji
    Kokawa, Yozo
    Miyasaka, Miwako
    Honda, Mariko
    Aoishi, Yuka
    Oku, Aya
    Nishimura, Yoshiharu
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S557 - S557
  • [8] Psoriasis patients generate increased serum levels of autoantibodies to tumor necrosis factor-α and interferon-α
    Bergman, R.
    Ramon, M.
    Wildbaum, G.
    Avitan-Hersh, E.
    Mayer, E.
    Shemer, A.
    Karin, N.
    JOURNAL OF DERMATOLOGICAL SCIENCE, 2009, 56 (03) : 163 - 167
  • [9] Infliximab and adalimumab, unlike ustekinumab, increase serum KL-6 levels in Japanese patients with psoriasis
    Yanaba, Koichi
    Umezawa, Yoshinori
    Sakakihara, Reiko
    Chiba, Miki
    Ito, Toshihiro
    Kikuchi, Sota
    Fukuchi, Osamu
    Asahina, Akihiko
    Saeki, Hidehisa
    Nakagawa, Hidemi
    JOURNAL OF DERMATOLOGY, 2015, 42 (08): : 828 - 829
  • [10] Secukinumab decreases serum Krebs von den Lungen 6 (KL-6) level in patients with psoriasis with elevated serum KL-6 level
    Chijiwa, C.
    Takeoka, S.
    Kamata, M.
    Uchida, H.
    Fukaya, S.
    Hayashi, K.
    Fukuyasu, A.
    Tanaka, T.
    Ishikawa, T.
    Ohnishi, T.
    Tada, Y.
    BRITISH JOURNAL OF DERMATOLOGY, 2018, 179 (06) : 1396 - 1397
12345